Detection of 13 Ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, Compound K, 20(S)-Protopanaxadiol, and 20(S)-Protopanaxatriol) in Human Plasma and Application of the Analytical Method to Human Pharmacokinetic Studies Following Two Week-Repeated Administration of Red Ginseng Extract

• Published in: Molecules (Basel, Switzerland) Vol. 24; no. 14; p. 2618
• Main Authors: Jin, Sojeong, Jeon, Ji-Hyeon, Lee, Sowon, Kang, Woo Youl, Seong, Sook Jin, Yoon, Young-Ran, Choi, Min-Koo, Song, Im-Sook
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 18.07.2019; MDPI
• Subjects: Accuracy; Bioavailability; Calibration; Chromatography; ginsenosides; Ginsenosides - blood; Ginsenosides - chemistry; Ginsenosides - pharmacokinetics; human; Human subjects; Humans; Mass spectrometry; Metabolic Networks and Pathways; Metabolites; Methods; Molecular Structure; Oral administration; Panax - chemistry; Pharmacokinetics; Plant Extracts - blood; Plant Extracts - chemistry; Plant Extracts - pharmacokinetics; Plasma; Proteins; red ginseng extract; Reproducibility of Results; Retention; Scientific imaging; Sensitivity and Specificity; Tandem Mass Spectrometry; pharmacokinetics; ginsenosides; human; red ginseng extract
• DOI: 10.3390/molecules24142618
• ISSN: 1420-3049

We aimed to develop a sensitive method for detecting 13 ginsenosides using liquid chromatography–tandem mass spectrometry and to apply this method to pharmacokinetic studies in human following repeated oral administration of red ginseng extract. The chromatograms of Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, compound K (CK), protopanaxadiol (PPD), and protopanaxatriol (PPT) in human plasma were well separated. The calibration curve range for 13 ginsenosides was 0.5–200 ng/mL and the lower limit of quantitation was 0.5 ng/mL for all ginsenosides. The inter- and intra-day accuracy, precision, and stability were less than 15%. Among the 13 ginsenosides tested, nine ginsenosides (Rb1, Rb2, Rc, Rd, Rg3, CK, Rh2, PPD, and PPT) were detected in the human plasma samples. The plasma concentrations of Rb1, Rb2, Rc, Rd, and Rg3 were correlated with the content in red ginseng extract; however, CK, Rh2, PPD, and PPT were detected although they are not present in red ginseng extract, suggesting the formation of these ginsenosides through the human metabolism. In conclusion, our analytical method could be effectively used to evaluate pharmacokinetic properties of ginsenosides, which would be useful for establishing the pharmacokinetic–pharmacodymic relationship of ginsenosides as well as ginsenoside metabolism in humans.